tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

NVCR Stock Latest News

NovoCure Announces Major Leadership Restructuring and New Roles
Company AnnouncementsNovoCure Announces Major Leadership Restructuring and New Roles
17d ago
8K
NVCR
Novocure announces planned CEO transition, COO to step down
PremiumThe Fly
Novocure announces planned CEO transition, COO to step down
17d ago
NVCR
Novocure presented positive results from the phase 3 METIS trial in June
PremiumThe Fly
Novocure presented positive results from the phase 3 METIS trial in June
2M ago
NVCR
Novocure reports Q2 EPS (31c), consensus (41c)
PremiumThe Fly
Novocure reports Q2 EPS (31c), consensus (41c)
2M ago
NVCR
Novocure reports Q2 EPS (31c), consensus (41c)
PremiumThe Fly
Novocure reports Q2 EPS (31c), consensus (41c)
2M ago
NVCR
NovoCure Ltd. (NVCR) Q2 Earnings Cheat Sheet
PremiumPre-EarningsNovoCure Ltd. (NVCR) Q2 Earnings Cheat Sheet
2M ago
NVCR
Novocure price target raised to $20 from $14.50 at Evercore ISI
Premium
The Fly
Novocure price target raised to $20 from $14.50 at Evercore ISI
3M ago
NVCR
NovoCure Shareholders Elect Directors and Endorse Key Proposals
Premium
Company Announcements
NovoCure Shareholders Elect Directors and Endorse Key Proposals
3M ago
8K
NVCR
Novocure announces METIS trial met primary endpoint
PremiumThe Fly
Novocure announces METIS trial met primary endpoint
4M ago
NVCR
Novocure releases topline efficacy data from TIGER study for glioblastoma
PremiumThe Fly
Novocure releases topline efficacy data from TIGER study for glioblastoma
4M ago
NVCR
Novocure management to meet with Piper Sandler
PremiumThe Fly
Novocure management to meet with Piper Sandler
4M ago
NVCR
Novocure management to meet with Piper Sandler
PremiumThe Fly
Novocure management to meet with Piper Sandler
4M ago
NVCR
Novocure reports Q1 EPS (36c), consensus (42c)
PremiumThe FlyNovocure reports Q1 EPS (36c), consensus (42c)
5M ago
NVCR
Novocure to present results of METIS phase 3 trial at ASCO 2024
Premium
The Fly
Novocure to present results of METIS phase 3 trial at ASCO 2024
5M ago
NVCR
Novocure price target raised to $28 from $25 at Piper Sandler
Premium
The Fly
Novocure price target raised to $28 from $25 at Piper Sandler
5M ago
NVCR
Novocure announces 20 presentations at AACR 2024
PremiumThe Fly
Novocure announces 20 presentations at AACR 2024
6M ago
NVCR
Novocure price target lowered to $42 from $49 at Wells Fargo
PremiumThe Fly
Novocure price target lowered to $42 from $49 at Wells Fargo
6M ago
NVCR
Novocure METIS results ‘not a home run,’ says H.C. Wainwright
PremiumThe Fly
Novocure METIS results ‘not a home run,’ says H.C. Wainwright
6M ago
NVCR
NovoCure trading resumes
PremiumThe Fly
NovoCure trading resumes
6M ago
NVCR
NovoCure trading halted, volatility trading pause
PremiumThe FlyNovoCure trading halted, volatility trading pause
6M ago
NVCR
Zai Lab says partner Novocure’s Phase 3 trial met primary endpoint
Premium
The Fly
Zai Lab says partner Novocure’s Phase 3 trial met primary endpoint
6M ago
NVCR
ZLAB
Novocure spikes 30% after drug trial met primary endpoint
Premium
The Fly
Novocure spikes 30% after drug trial met primary endpoint
6M ago
NVCR

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >